X

Health Care

Rite Aid Corporation (RAD) Q4 2023 net loss narrows

Drugstore chain Rite Aid Corporation (NYSE: RAD) announced fourth-quarter 2023 results, reporting a modest increase in revenues and a narrower…

Ocean Biomedical co-founder Jack Elias to receive US patent for pulmonary fibrosis treatments

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biopharma company that works with research universities and medical centers for developing and…

Abbott Laboratories (ABT) Q1 2023 Earnings Call Transcript

Abbott Laboratories (NYSE: ABT) Q1 2023 earnings call dated Apr. 19, 2023 Corporate Participants: Scott Leinenweber -- Vice President, Investor Relations, Licensing…

Intuitive Surgical (ISRG) looks poised for a strong year ahead

The healthcare industry has been witnessing an increase in demand for robotic-assisted surgical procedures due to their high efficiency and…

Intuitive Surgical (ISRG) Q1 adj. profit and revenue increase

Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) announced operating results for the first quarter of 2023, reporting higher revenues…

Infographic: Highlights of Abbott Laboratories’ Q1 2023 results

Healthcare company Abbott Laboratories (NYSE: ABT) announced financial results for the first quarter of 2023, reporting a decline in net…

Intuitive Surgical, Inc. (ISRG) Q1 2023 Earnings Call Transcript

Intuitive Surgical, Inc. (NASDAQ: ISRG) Q1 2023 earnings call dated Apr. 18, 2023 Corporate Participants: Brian King -- Treasurer and Head of Investor…

Intuitive Surgical Inc (ISRG) Q1 2023 Earnings Call Transcript

Intuitive Surgical Inc (NASDAQ:ISRG) Q1 2023 Earnings Call dated Apr. 18, 2023. Corporate Participants: Brian King -- Treasurer and Head of Investor…

Johnson & Johnson (JNJ) Q1 2023 Earnings Call Transcript

Johnson & Johnson (NYSE: JNJ) Q1 2023 earnings call dated Apr. 18, 2023 Corporate Participants: Jessica Moore -- Vice President, Investor Relations…

JNJ Earnings: All you need to know about Johnson & Johnson’s Q1 2023 earnings results

Johnson & Johnson (NYSE: JNJ) reported its first quarter 2023 earnings results today. Reported sales increased 5.6% year-over-year to $24.7 billion.…

The future looks bright for UnitedHealth Group (UNH). Is the stock a buy?

Health insurance companies have been witnessing a decline in claims lately as non-urgent medical procedures are being deferred due to…

Ocean Biomedical (OCEA) announces $134 million financial backing for innovative research and IND filings

Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company that works with research universities and medical centers for developing and commercializing…

UnitedHealth Group Incorporated (UNH) Q1 2023 Earnings Call Transcript

UnitedHealth Group Incorporated (NYSE: UNH) Q1 2023 earnings call dated Apr. 14, 2023 Corporate Participants: Andrew Witty -- Chief Executive Officer Dirk…

UnitedHealth Group (UNH) Earnings: 1Q23 Key Numbers

UnitedHealth Group (NYSE: UNH) reported first quarter 2023 earnings results today. Revenues grew 15% year-over-year to $92 billion, helped by…

Ocean Biomedical gets Notice of Allowance for US patent application for developing new malaria therapeutics

Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company that works with research universities and medical centers for developing and commercializing…

What to expect when UnitedHealth Group (UNH) reports Q1 2023 earnings

Shares of UnitedHealth Group Inc. (NYSE: UNH) stayed green on Wednesday. The stock has gained nearly 6% over the past…

Organigram Holdings, Inc (OGI) Q2 2023 Earnings Call Transcript

Organigram Holdings, Inc. (NASDAQ: OGI) Q2 2023 earnings call dated Apr. 12, 2023 Corporate Participants: Max Schwartz -- Director of Investor Relations…

Continued focus on core B2B segment drives new business: Trxade CEO Suren Ajjarapu

Trxade Health Inc. (NASDAQ: MEDS), a leading online drug procurement marketplace, is on a mission to provide independent pharmacies a…

Key factors to consider before investing in Abbott Laboratories (ABT)

Abbott Laboratories (NYSE: ABT) has contributed significantly to COVID care activities by providing test kits, and the healthcare conglomerate’s revenues…

Ocean Biomedical (OCEA) announces new findings in relation to treatment options for Hermansky-Pudlak Syndrome

Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) announced its commitment to developing viable treatment options for Hermansky-Pudlak Syndrome (HPS) on…

CVS Health Corporation (CVS) bets big on primary care. What future holds

Retail pharmacy chain CVS Health Corporation (NYSE: CVS) has been diversifying with the aim of tapping into emerging opportunities, while…